[144] ARGAN INC SEC Filing
Rhea-AI Filing Summary
Form 144 notice for ARGAN INC (AGX) reports a proposed sale of common shares by an insider through Morgan Stanley Smith Barney. The filer plans to sell 2,609 shares with an aggregate market value of $625,325.12 on the NYSE, and reports the acquisition of those shares on 09/17/2025 by exercising options under a registered plan and paying cash on the same date. The filing also discloses prior sales by the same person: 3,465 shares sold on 06/26/2025 for $734,630.59. The notice includes the seller's representation that no undisclosed material adverse information is known.
Positive
- Clear compliance disclosure with broker, share counts, and acquisition method provided
- Seller representation that no undisclosed material adverse information is known
Negative
- None.
Insights
TL;DR: Routine insider sale notice showing option exercise and planned disposition of 2,609 AGX shares; appears non-material for valuation.
The filing documents a standard Form 144 notification: the holder exercised options and intends to sell the resulting 2,609 shares through Morgan Stanley Smith Barney on the NYSE at an indicated aggregate market value of $625,325.12. The filing also lists a recent sale of 3,465 shares for $734,630.59 on 06/26/2025. There is no earnings, debt, or operational information in this filing, so material impact on company fundamentals is not shown here.
TL;DR: Filing meets Rule 144 disclosure mechanics; includes required rep that no undisclosed material adverse information exists.
The submission includes required seller representations and signature admonitions concerning false statements. It specifies the broker, sale date, and that the securities were acquired by exercising options under a registered plan and paid in cash. From a governance perspective, the document is a routine compliance disclosure and contains the typical certifications to satisfy Rule 144 and exchange requirements.